New Perspectives in Pediatric Liver Transplantation

Welcome Reception & Poster Session

Monday October 16, 2023 - 17:00 to 19:00

Room: Montréal 1-4

P-38 Heart-Liver transplantation in a patient with hepatocellular carcinoma secondary to Fontan-associated liver disease

Guillermo A Costaguta, Canada

CHU Sainte-Justine

Abstract

Heart-Liver transplantation in a patient with hepatocellular carcinoma secondary to Fontan-associated liver disease

Guillermo Costaguta1, Leticia Khendek1, Mona Beaunoyer2,4, Nancy Poirier3,4, Marie-Josée Raboisson3,4, Massimiliano Paganelli1,4,5.

1Gastroenterology, Hepatology and Nutrition, CHU Sainte-Justine, Montreal, QC, Canada; 2Department of Surgery, CHU Sainte-Justine, Montreal, QC, Canada; 3Department of Cardiology, CHU Sainte-Justine, Montreal, QC, Canada; 4Department of Pediatrics, University of Montrealrsity, Montreal, QC, Canada; 5Liver Tissue Engineering and Cell Therapy, Research Center of the CHU Sainte-Justine, Montreal, QC, Canada

Introduction: Fontan procedure is the palliative treatment for univentricular heart diseases. Fontan-associated liver disease (FALD) develops almost universally. Here we present a case of combined heart-liver transplantation in a pediatric patient with FALD and hepatocellular carcinoma (HCC).

Case Report: A female patient with left ventricular hypoplastic syndrome and previous Fontan procedure was diagnosed with FALD at 9 years of age. Three years later (7 years post-Fontan), 6 liver nodules were diagnosed, two of which showed early washout. The lesions increased in size over months. Biopsy showed high-grade dysplasia of the dominant nodule, which, combined with the radiological findings, was considered compatible with an early HCC. The patient was listed for heart-liver transplantation at the age of 14, and chemoembolization was performed on the dominant nodule. Combined sequential heart-liver transplant was mainly uneventful, except for prolonged reperfusion times secondary to a complicated pulmonary artery suture. After surgery, normalization of liver enzymes was delayed by high-dose vasopressors and transient, mildly decreased right ventricular function. The patient rapidly recovered and was dismissed with normal liver function tests. Low-grade dysplasia was confirmed in all nodules at histology, with complete necrosis of the dominant lesion post-chemoembolization.

Conclusion: We report here the first successful pediatric heart-liver transplant in Canada. Combined transplantation for FALD-induced HCC during adolescence offers the advantage of a still satisfying heart function and absent or negligible liver failure. Nevertheless, diagnosis of HCC in FALD patients is complex, best timing for surgery is unclear, and organ allocation in these patients remains an open question.

Organized by

A section of

If you have any questions during the meeting, please go to the registration desk. Our emails will be monitored sporadically.

REGISTRATION DESK OPENING TIMES
Sunday, October 15, 16:00-18:00 Monday, October 16, 07:00-18:00 Tuesday October 17, 07:00-12:30

© 2024 SPLIT 2023